Weilang Wang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Response to Letter to the Editor Regarding 'Practical Considerations for MRI-Derived Retreatment Response Scores in Viable HCC'.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 26, 2026
Response to Letter to the Editor Regarding 'Considerations on MRI-Based Stratification for Retreatment After TACE in HCC'.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 20, 2026
MR Radiomics Combined With Radiologic Features to Predict Recurrence Location in Nonviable Hepatocellular Carcinoma After Transarterial Chemoembolization.
Journal: Journal of gastroenterology and hepatology
Published: November 20, 2025
MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 18, 2025
The nVR model: prediction of LI-RADS treatment response nonviable recurrence of hepatocellular carcinoma after primary transarterial chemoembolization.
Journal: Abdominal radiology (New York)
Published: February 08, 2025
Transient hepatic intensity differences: correlations with treatment outcomes and adverse events following DEB-TACE in hepatocellular carcinoma.
Journal: Insights into imaging
Published: February 07, 2025
LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features.
Journal: AJR. American journal of roentgenology
Published: November 13, 2024
Dynamic changes of radiological and radiomics patterns based on MRI in viable hepatocellular carcinoma after transarterial chemoembolization.
Journal: Abdominal radiology (New York)
Published: September 14, 2024
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: September 11, 2024
Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis.
Journal: Abdominal radiology (New York)
Published: October 17, 2023
Effects of Low-Osmolar Contrast Media on Long-Term Renal Impairment After Coronary Angiography: Iohexol Versus Iopromide.
Journal: The American journal of cardiology
Published: August 28, 2023
MicroRNA-30/Cx43 axis contributes to podocyte injury by regulating ER stress in diabetic nephropathy.
Journal: Annals of translational medicine
Published: January 25, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026